Ms. Walmsley’s nomination will be voted on at Microsoft’s annual shareholders meeting in December. If elected, she will become the fifth woman on the tech giant’s 13-member board, up from just two in 2015, per CNBC.
The board’s other female members are Teri List-Stoll, executive vice president and CFO of Gap; Sandra Peterson, operating partner at Clayton, Dubilier & Rice; Penny Pritzker, founder and chair of PSP Partners and former U.S. secretary of commerce; and Padmasree Warrior, founder, president and CEO of Fable Group.
“Emma is an accomplished business leader who led major advances in research and development at GSK and will bring her significant insights and global experience to Microsoft,” John W. Thompson, Microsoft’s independent board chair, said in the filing. “We believe she will be a valuable addition to the board.”
More articles on health IT:
OSF HealthCare joins funding for precision medicine software startup InsightRX
Movers and shakers: 10 latest leadership changes affecting health IT
Epic CEO Judy Faulkner on ‘yes, if’ strategy behind company’s culture, success & 11 other health IT notes
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.